SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-136387
Filing Date
2021-11-09
Accepted
2021-11-09 17:26:04
Documents
4
Effectiveness Date
2021-11-09

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2132065d1_s8.htm S-8 55303
2 EXHIBIT 5.1 tm2132065d1_ex5-1.htm EX-5.1 24256
3 EXHIBIT 23.2 tm2132065d1_ex23-2.htm EX-23.2 2352
4 GRAPHIC tm2132065d1_ex5-1img01.jpg GRAPHIC 4833
  Complete submission text file 0001104659-21-136387.txt   89829
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-260927 | Film No.: 211393389
SIC: 2834 Pharmaceutical Preparations